Anthem Blue Cross Blue Shield will cover Avedro’s Photrexa formulations and KXL System for corneal cross-linking, the company announced in a press release.
This brings the number of commercial payers covering the procedure to 60, including the U.S.’s largest payers United Healthcare, Anthem Blue Cross Blue Shield, Aetna, Cigna, Humana and HealthNet, the release said.
“In the past month alone, our Photrexa drug formulations were issued a permanent J code from CMS, and we added an additional 40 million lives who can access cross-linking,” Avedro CEO Reza Zadno, PhD, said
Uncategorized